BenevolentAI (AMS: BAI) is a leading developer of advanced artificial intelligence technologies that unlock the value of multimodal data, surface novel insights, and accelerate biomedical discovery.

Through the combined capabilities of its AI platform, its scientific expertise, and wet-lab facilities, the Company is developing an inhouse drug pipeline of high-value assets. The Company is headquartered in London, with a research facility in Cambridge (UK).

Press contacts

FTI Consulting
Ben Atwell, Simon Conway, Victoria Foster Mitchell 
+44 (0) 20 3727 1000

Sign up for our news